The neurological biomarkers market is rapidly growing due to advancements in diagnostics and treatment of neurological disorders like Alzheimer's, Parkinson's, and multiple sclerosis. Rising prevalence of these conditions, coupled with technological innovations in biomarker discovery, is driving demand. Biomarkers enhance early diagnosis, personalized medicine, and drug development, fueling market expansion globally. Visit us: https://www.imarcgroup.com/neurological-biomarkers-market